Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XTLB Xtl生物制药

盘后交易 02-10 17:19:10 EST

0.9300

-0.0236

-2.47%

最高0.9990	最低0.9300	成交量7,094
今开0.9579	昨收0.9536	日振幅7.24%
总市值880.00万	流通市值480.58万	总股本946.24万
成交额6,839	换手率0.14%	流通股本516.75万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":0.93,"timestamp":1770757200000,"preClose":0.9536,"halted":0,"volume":7094,"delay":0,"changeRate":-0.024748322147650957,"floatShares":5167500,"shares":9462400,"eps":-1.1996,"marketStatus":"盘后交易","change":-0.0236,"latestTime":"02-10 17:19:10 EST","open":0.9579,"high":0.999,"low":0.93,"amount":6838.736598,"amplitude":0.072357,"askPrice":0.999,"askSize":100,"bidPrice":0.5802,"bidSize":300,"shortable":0,"etf":0,"ttmEps":-1.1996,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"adrRate":100,"exchange":"NASDAQ","adjPreClose":0.9536,"preHourTrading":{"tag":"盘前","latestPrice":0.95,"preClose":0.9676,"latestTime":"08:00 EST","volume":1,"amount":0.95,"timestamp":1770728408983,"change":-0.0176,"changeRate":-0.018189,"amplitude":0},"volumeRatio":0.062204},"requestUrl":"/m/hq/s/XTLB/tweets","defaultTab":"tweets","newsList":[{"id":"2605461861","title":"Xtl生物制药盘中异动 股价大跌8.12%报0.889美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605461861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605461861?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:31","pubTimestamp":1769005873,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时31分，Xtl生物制药股票出现波动，股价急速下挫8.12%。截至发稿，该股报0.889美元/股，成交量3750股，换手率0.04%，振幅1.14%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.04%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。hCDR1是一种合成肽，包含大约20个氨基酸残基。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223113a4460f66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223113a4460f66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2603665932","title":"Xtl生物制药盘中异动 大幅拉升21.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665932?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:31","pubTimestamp":1768314678,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时31分，Xtl生物制药股票出现异动，股价急速拉升21.55%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.21%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223118a4bf49df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223118a4bf49df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2601519847","title":"Xtl生物制药盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601519847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601519847?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:56","pubTimestamp":1767711384,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时56分，Xtl生物制药股票出现波动，股价快速上涨5.11%。截至发稿，该股报0.666美元/股，成交量1.206万股，换手率0.14%，振幅1.89%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.03%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106225624a4a3e79d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106225624a4a3e79d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2588774147","title":"Xtl生物制药盘中异动 急速上涨10.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774147?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:30","pubTimestamp":1764599437,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时30分，Xtl生物制药股票出现波动，股价快速上涨10.40%。截至发稿，该股报0.920美元/股，成交量2.7113万股，换手率0.31%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。hCDR1是一种合成肽，包含大约20个氨基酸残基。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230379789e658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230379789e658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2586239288","title":"Xtl生物制药盘中异动 临近收盘股价大跌7.09%报0.775美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586239288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586239288?lang=zh_cn&edition=full","pubTime":"2025-11-26 04:46","pubTimestamp":1764103619,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日04时46分，Xtl生物制药股票出现异动，股价大幅跳水7.09%。截至发稿，该股报0.775美元/股，成交量2.487万股，换手率0.28%，振幅6.47%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.81%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126044700951a2c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126044700951a2c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2586117074","title":"Xtl生物制药盘中异动 早盘快速拉升5.13%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586117074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586117074?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:31","pubTimestamp":1763994681,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时31分，Xtl生物制药股票出现波动，股价快速上涨5.13%。截至发稿，该股报0.810美元/股，成交量2864股，换手率0.03%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.35%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223121a70e89f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223121a70e89f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2585716754","title":"Xtl生物制药盘中异动 临近收盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585716754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585716754?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:37","pubTimestamp":1763671048,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时37分，Xtl生物制药股票出现波动，股价快速下跌5.33%。截至发稿，该股报0.815美元/股，成交量1.5991万股，换手率0.18%，振幅8.36%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.50%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112104372897762cd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112104372897762cd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2575135427","title":"Xtl生物制药盘中异动 早盘股价大涨6.87%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575135427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575135427?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:32","pubTimestamp":1760535159,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时32分，Xtl生物制药股票出现波动，股价急速拉升6.87%。截至发稿，该股报1.40美元/股，成交量5.2603万股，换手率0.60%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.26%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521323994caf58e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521323994caf58e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2567677124","title":"Xtl生物制药盘中异动 急速下挫7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567677124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567677124?lang=zh_cn&edition=full","pubTime":"2025-09-16 00:07","pubTimestamp":1757952444,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日00时07分，Xtl生物制药股票出现波动，股价快速下挫7.37%。截至发稿，该股报1.25美元/股，成交量1935股，换手率0.02%，振幅7.41%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.13%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916000725a4c7c31c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916000725a4c7c31c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2558753667","title":"Xtl生物制药盘中异动 股价大涨8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558753667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558753667?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:27","pubTimestamp":1754940459,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时27分，Xtl生物制药股票出现异动，股价急速拉升8.09%。截至发稿，该股报1.47美元/股，成交量2520股，换手率0.03%，振幅5.88%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.44%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032739a6e016da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812032739a6e016da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2557303063","title":"Xtl生物制药盘中异动 早盘快速上涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303063?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:42","pubTimestamp":1754491323,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时42分，Xtl生物制药股票出现异动，股价大幅拉升6.54%。截至发稿，该股报1.54美元/股，成交量1.1687万股，换手率0.13%，振幅9.32%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.10%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd致力于开发治疗未满足医疗需求的疗法。rHuEPO在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224203a478f61f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224203a478f61f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2518201241","title":"Xtl生物制药盘中异动 股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518201241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518201241?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:46","pubTimestamp":1741632408,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时46分，Xtl生物制药股票出现异动，股价大幅下挫6.40%。截至发稿，该股报1.17美元/股，成交量1.3337万股，换手率0.15%，振幅6.98%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.56%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102464898a2d9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102464898a2d9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2516890608","title":"Xtl生物制药盘中异动 早盘股价大跌5.16%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516890608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516890608?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098729,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Xtl生物制药股票出现异动，股价急速下挫5.16%。截至发稿，该股报1.33美元/股，成交量8130股，换手率0.09%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.25%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223209abe7efa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223209abe7efa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2516955632","title":"Xtl生物制药盘中异动 早盘股价大涨7.03%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516955632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516955632?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012270,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Xtl生物制药股票出现波动，股价快速上涨7.03%。截至发稿，该股报1.37美元/股，成交量1323股，换手率0.02%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.21%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223110abe632bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223110abe632bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2514378101","title":"Xtl生物制药盘中异动 股价大跌9.42%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378101?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Xtl生物制药股票出现波动，股价急速下挫9.42%。截至发稿，该股报1.25美元/股，成交量927股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.05%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223233abe0eac3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223233abe0eac3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2514038107","title":"Xtl生物制药盘中异动 快速上涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514038107?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:45","pubTimestamp":1740671102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时45分，Xtl生物制药股票出现波动，股价大幅拉升6.87%。截至发稿，该股报1.40美元/股，成交量369股，换手率0.00%，振幅6.11%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.85%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234503a2568d3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234503a2568d3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2514852741","title":"Xtl生物制药盘中异动 股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514852741?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:00","pubTimestamp":1740585617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时00分，Xtl生物制药股票出现异动，股价大幅上涨5.63%。截至发稿，该股报1.50美元/股，成交量2720股，换手率0.03%，振幅4.23%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.05%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000017abde0220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000017abde0220&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2514321019","title":"Xtl生物制药股价重挫16.78% 市值跌42.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514321019?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:51","pubTimestamp":1740498709,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时51分，Xtl生物制药股票出现波动，股价大幅跳水16.78%。截至发稿，该股报1.19美元/股，成交量525股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.78%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252351499630047b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252351499630047b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2513917702","title":"Xtl生物制药盘中异动 早盘股价大跌5.96%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513917702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513917702?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:12","pubTimestamp":1740150721,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时12分，Xtl生物制药股票出现波动，股价急速跳水5.96%。截至发稿，该股报1.42美元/股，成交量1793股，换手率0.02%，振幅0.66%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.13%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221231201a24eba58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221231201a24eba58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2512848487","title":"Xtl生物制药盘中异动 早盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848487?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:21","pubTimestamp":1739982061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时21分，Xtl生物制药股票出现异动，股价急速上涨5.81%。截至发稿，该股报1.64美元/股，成交量322股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.45%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002101a24c108e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002101a24c108e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0.1407},{"period":"1month","weight":0.4157},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.3261},{"period":"1year","weight":-0.3726},{"period":"ytd","weight":0.6441}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发，为了满足未得到满足的医疗需求。最近在致力于MM的治疗，精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.121456},{"month":2,"riseRate":0.411765,"avgChangeRate":-0.026276},{"month":3,"riseRate":0.375,"avgChangeRate":0.154077},{"month":4,"riseRate":0.4375,"avgChangeRate":-0.01928},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.059048},{"month":6,"riseRate":0.466667,"avgChangeRate":0.000234},{"month":7,"riseRate":0.4375,"avgChangeRate":0.469627},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.037628},{"month":9,"riseRate":0.1875,"avgChangeRate":-0.076581},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.025328},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.062792},{"month":12,"riseRate":0.235294,"avgChangeRate":-0.064989}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}